This is all looking fine to me. The market is bad and if AZG (like many other companies in the same boat) continues to perform, then all will be rosy for AZG and us shareholders when the market improves.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025